SurgaColl
Dublin · Founded 2010
About SurgaColl
SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien, the company aims to become a leader in the field of regenerative medical devices.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2018)
- Website: http://surgacoll.com/
- Phone: +353 (0)1 700 7022
Industries & Categories
Health Care, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/surgacoll-1936 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.